Skip to content
+91 22 42221111
compliance@sudarshanpharma.com
Search:
Sudarshan Pharma Industries Ltd.
Pharma and Specialty Chemicals
Sudarshan Pharma Industries Ltd.Sudarshan Pharma Industries Ltd.
  • Home
  • Company Overview
    • About us
    • Business Model
    • Executive Leadership
    • Our Locations
    • Awards & Accolades
    • Corporate Presentation
  • Business Segments
    • Chemicals
      • Specialty Chemicals
      • Purification, LR, AR, material as per IP, BP, USP
      • Manufacturing
    • Pharmaceuticals
      • Ethical division
      • Generic Institution supply
      • Manufaturing Export
      • Intermediates Manufacturing
      • API Manufacturing
      • API Contract Manufacturing
      • Inhalers Manufacturing
  • Investors/Disclosures under Reg 46 of LODR
    • Corporate Information
    • Overview
    • Financial Information
    • Reports & Presentation
    • Disclosures
      • Board of Directors
      • Board Meeting Intimation and Outcome
      • Shareholders Meeting
      • Corporate Action
      • Newspaper Advertisements
      • Grievance Redressal
      • Business Details
      • Key Managerial Persons
      • Shareholding Pattern
      • SEBI (SAST) Regulations, 2011
      • SEBI (PIT) Regulations 2015
      • Investors Complaint
    • Other Investor Information
      • Codes and Policies
      • Investor Relation
      • Investor Presentations
      • Corporate Governance
      • Corporate Announcements
      • Annual Reports and Annual Returns
      • Financial Results
      • Statement of Deviation / Variation
      • Statutory Disclosure
      • Initial Public Offering
  • Sustainability
    • Focus Areas
    • CSR
  • Media
    • Press Release
    • News & Events
    • Gallery
    • Clientele
  • Careers
    • People & Culture
    • Recruitment Process
    • Current Openings
    • Apply Now
  • Contact
    • Contact us
    • FAQ
  • Home
  • Company Overview
    • About us
    • Business Model
    • Executive Leadership
    • Our Locations
    • Awards & Accolades
    • Corporate Presentation
  • Business Segments
    • Chemicals
      • Specialty Chemicals
      • Purification, LR, AR, material as per IP, BP, USP
      • Manufacturing
    • Pharmaceuticals
      • Ethical division
      • Generic Institution supply
      • Manufaturing Export
      • Intermediates Manufacturing
      • API Manufacturing
      • API Contract Manufacturing
      • Inhalers Manufacturing
  • Investors/Disclosures under Reg 46 of LODR
    • Corporate Information
    • Overview
    • Financial Information
    • Reports & Presentation
    • Disclosures
      • Board of Directors
      • Board Meeting Intimation and Outcome
      • Shareholders Meeting
      • Corporate Action
      • Newspaper Advertisements
      • Grievance Redressal
      • Business Details
      • Key Managerial Persons
      • Shareholding Pattern
      • SEBI (SAST) Regulations, 2011
      • SEBI (PIT) Regulations 2015
      • Investors Complaint
    • Other Investor Information
      • Codes and Policies
      • Investor Relation
      • Investor Presentations
      • Corporate Governance
      • Corporate Announcements
      • Annual Reports and Annual Returns
      • Financial Results
      • Statement of Deviation / Variation
      • Statutory Disclosure
      • Initial Public Offering
  • Sustainability
    • Focus Areas
    • CSR
  • Media
    • Press Release
    • News & Events
    • Gallery
    • Clientele
  • Careers
    • People & Culture
    • Recruitment Process
    • Current Openings
    • Apply Now
  • Contact
    • Contact us
    • FAQ

7. Albums masonry – backgr. overlay

View allAwardsChemspec India ExhibitionClientGalleryPress Release
Sort by dateSort by name
DescendingAscending

Ratna Lifescience

Gallery

Ratna Lifescience Factory

Palghar Factory

Gallery

Palghar Factory

Extraordinary General Meeting held on 30th September 2024

Gallery

16th Annual General Meeting held on 30th September 2024

Gallery

Heart Kit Banner

Gallery

Padma Shri Dr. G. Bakthavathsalam with SPIL Chairman Sri Hemal Mehta

Gallery

Client

Client

First Aid awareness – 21st April 2019

Gallery

Chemspec India Exhibition

Chemspec India Exhibition

Awards & Accolades

Awards

Press Release

Press Release

Dolor a nisl ac nibh venenatis ultricies. Donec ut velit vitae purus consequat feugiat in sed nisl.

Load more
Business segments
  • Specialty Chemicals
  • Intermediates
  • Ethical division
  • Generic Institution supply
  • Exports
  • API
Quick Links
  • Home
  • About us
  • Executive Leadership
  • Corporate Presentation
  • CSR
  • People in culture
  • Current openings
Investors
  • Overview
  • Financial Information
  • Reports & Presentation
  • Stock Information
Contact Us
Sudarshan Pharma Ind. Ltd.
  • Address
    301, 3rd Floor, Aura Biplex Landmark Kalyan Jewellers, S V Road, Borivali (W), Mumbai - 400092. Maharashtra. India.
  • Contact
    +91-22-42221111 (Board Line)
    +91-22-42221123 / +91-22-42221160
  • E-mail
    For Export:
    sudarshangroupexports@gmail.com
    For Local:
    sachinchemicals@gmail.com
    purchase@sudarshanpharma.com

Find us on:

Facebook page opens in new windowLinkedin page opens in new window
Sudarshan Pharma Industries Ltd.
© All Rights Reserved 2019 Sudarshan Pharma | Website Design by Apex Solutions
  • Privacy Policy
Useful links
Go to Top

Important Notice: Beware of Fraudulent Emails

Dear Valued Visitors,

It has come to our attention that there have been instances of fraudulent activity through email correspondence impersonating Sudarshan Pharma Industries Limited. These fraudulent emails may request sensitive information, contain harmful links, or malicious attachments.

To ensure the security of your interactions with us, please take note of the following:

  1. Verify Email Identities: Before responding to any email claiming to be from Sudarshan Pharma Industries Limited, please double-check the sender's email address. Our authorized email address for business transactions is [Authorized Email Address].
  2. Exercise Caution: If you receive any suspicious emails, refrain from clicking on any links or downloading attachments. These emails could potentially compromise the security of your system.
  3. Report Suspicious Activity: If you encounter any suspicious emails or activities, please notify us immediately via phone or email.

Your safety and security are of utmost importance to us. Thank you for your attention to this matter.

Best regards,

Sudarshan Pharma Industries Limited